PomDoctor, Ltd.
Case Overview
| Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 04/06/2026 |
| Status: | Status: Investigating |
| Company Name: | Company Name: PomDoctor, Ltd. |
| Court: | Court: Southern District of New York |
| Case Number: | Case Number: 1:26cv01013 |
| Class Period: | Class Period: 10/09/2025 - 12/11/2025 |
| Ticker: | Ticker: POM |
| Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
| Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired (“PomDoctor” or the “Company”) NASDAQ: POM securities during the period of October 9, 2025 through December 11, 2025, inclusive (“the Class Period”).
According to the lawsuit, defendants failed to disclose to investors: (i) that PomDoctor was the subject of a fundamental stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) that PomDoctor's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity during the stock price.
In the weeks leading up to the December 10, 2025 initial public offering ("IPO"), PomDoctor's share price surged from the IPO price of $4.00 to an all-time high of $6.09, despite not fundamental news from the Company justifying the spike. Investigations and public reports have since revealed that PomDoctor utilized social media to orchestrate an illicit "pump-and-dump" scheme to defraud investors. Allegedly, impersonators claiming to be legitimate financial advisors touted PomDoctor in online forums, chat groups, and through social media posts with sensational but baseless claims to create a buying frenzy among retail investors. On December 10, 2025, PomDoctor's share price crashed by approximately 91% to $0.50. The Company's share price has continued to decline to approximately $0.40.